Chromosome 1q expression profiling and relapse in Wilms' tumour

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Gene-expression patterns are crucial for accurate tumor classification and prognosis.
• Wilms' tumour, a common pediatric kidney cancer, requires reliable methods for predicting patient outcomes.
• Identifying specific genetic markers associated with tumor behavior is essential for targeted therapies.

Purpose of the Study:

• To evaluate a novel gene-expression profiling technique, comparative expressed sequence hybridisation (CESH), for its ability to predict Wilms' tumour relapse.
• To determine if specific chromosomal gene expression patterns correlate with tumor behavior and patient prognosis.
• To assess the utility of CESH in identifying chromosomal regions with genes critical for tumor development.

Main Methods:

• Comparative expressed sequence hybridisation (CESH) was employed to analyze gene expression in 18 cases of Wilms' tumour.
• The study focused on tumors with favourable histological findings.
• Gene expression levels were correlated with patient relapse and remission status.

Main Results:

• A significant association was found between the relative overexpression of genes on the long arm of chromosome 1 and tumor relapse.
• All tumors from patients who relapsed exhibited this overexpression, while none from patients in remission did (odds ratio 357).
• This finding highlights a strong predictive value for relapse in Wilms' tumour.

Conclusions:

• Comparative expressed sequence hybridisation (CESH) analysis is a valuable tool for rapidly screening chromosomal regions associated with differential gene expression.
• The identified overexpression of genes on chromosome 1 long arm serves as a potential biomarker for predicting Wilms' tumour relapse.
• CESH facilitates the identification of genes critical to tumor behavior, aiding in prognosis and potentially guiding treatment strategies.